SAVE Moms and Babies Act of 2023

This bill prohibits the FDA from approving new abortion drugs and restricts existing approved drugs to in-person administration by certified healthcare providers. It requires providers to be certified in pregnancy assessment, ectopic pregnancy diagnosis, and emergency care capabilities, and mandates that drugs can only be dispensed in clinics, offices, or hospitals. The bill also imposes new reporting requirements for adverse events (like hospitalizations or severe infections) and requires providers to document risks to patients before prescribing. These provisions apply to all drugs defined as "abortion drugs" under the bill, which includes any substance intended to terminate pregnancy (excluding specific medical exceptions).